Literatur
Daley CL, Iaccarino JM, Lange C, et al. Treatment of nontuberculous mycobacterial pulmonary disease: an official ATS/ERS/ESCMID/IDSA clinical practice guideline. Eur Respir J 2020; 56: 2000535 [https://doi.org/10.1183/13993003.00535-2020].
Winthrop KL, Marras TK, Adjemian J et al. Incidence and Prevalence of Nontuberculous Mycobacterial Lung Disease in a Large U.S. Managed Care Health Plan, 2008-2015. Ann Am Thorac Soc. 2020 Feb;17(2):178-185. doi: 10.1513/AnnalsATS.201804-236OC.
Ringshausen F, Wagner D, de Roux A et al. Prevalence of Nontuberculous Mycobacterial Pulmonary Disease, Germany, 2009-2014 Emerg Infect Dis. 2016 Jun; 22(6): 1102-05
Adjemian J, Daniel-Wayman S, Ricotta E, Prevots DR. Epidemiology of nontuberculous mycobacteriosis. Semin Respir Crit Care Med 2018; 39: 325-35
Priscilla P, Ly P, Dillard R et al. Medical Tourism and Postoperative Infections: A Systematic Literature Review of Causative Organisms and Empiric Treatment. Plastic and Reconstructive Surgery. 2018; 142(6):1644-51
Becker SL, Schlotthauer U, Schäfers HJ et al. Epidemiology, Clinical Presentation, Diagnosis and Treatment of Infections Caused by Mycobacterium chimaera. Pneumologie. 2019 Aug;73(8):474-81 doi: 10.1055/a-0872-880
J van Ingen, S A Bendien, W C M de Lange et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax 2009 Jun;64(6):502-6. doi: 10.1136/thx.2008.110957.
David E. Griffith, Timothy Aksamit, Barbara A. Brown-Elliott et al. on behalf of the ATS Mycobacterial Diseases Subcommittee. An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases. Am J Respir Crit Care Med 2007. Vol 175. pp 367-416
Mirsaeidi M, Hadid W, Ericsoussi B et al. Non-tuberculous mycobacterial disease is common in patients with non-cystic fibrosis bronchiectasis. Int J Infect Dis. 2013;17:e1000-4.
Reich JM, Johnson RE. Mycobacterium avium complex pulmonary disease presenting as an isolated lingular or middle lobe pattern. The Lady Windermere syndrome. Chest 1992;101(6):1605-09. http://dx.doi.org/10.1378/chest. 101.6.1605
Andrejak C, Nielsen R, Thomsen VO et al.Chronic respiratory disease, inhaled corticosteroids and risk of nontuberculous mycobacteriosis. Thorax. 2012;68:256-6
Lake A, Ambrose L, Lipman M, Lowe D. "Why me, why now?" Using clinical immunology and epidemiology to explain who gets nontuberculous mycobacterial infection BMC Medicine 2016; 14:54
Griffith DE, Aksamit T, Brown-Elliott BA et al. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med 2007; 175: 367-416
Mehta M, Marras TK. Impaired health-related quality of life in pulmonary nontuberculous mycobacterial disease. Respir Med 2011; 105:1718-25
Richter R, Andres R, Diehl R et al. Tuberkulose, Mykobakteriose MiQ 05 (3. Auflage) 2019
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Heiß-Neumann, M., Avsar, K. Nichttuberkulösen Mykobakteriosen der Lunge auf der Spur. Pneumo News 13, 41–47 (2021). https://doi.org/10.1007/s15033-021-2698-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s15033-021-2698-8